Dier Mardi
SEC insider (Form 3/4/5 filer). CIK 0001574591. EVP and CFO at MADRIGAL PHARMACEUTICALS, INC. (MDGL) and 2 other issuers. 37 reported Form 4/5 transactions since Sep 2024; latest on Mar 6, 2026. Located in WEST CONSHOHOCKEN, PA.
Companies Dier Mardi has filed insider reports for
- MADRIGAL PHARMACEUTICALS, INC. (MDGL): Officer, EVP and CFO
- Oric Pharmaceuticals, Inc. (ORIC): Director
- Prelude Therapeutics Inc (PRLD): Director
Dier Mardi
CIK: 0001574591
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (37 total)
- Mar 6, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect116 shares at avg. $432.56$50K - Mar 6, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect160 shares at avg. $434.20$69K - Mar 6, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect646 shares at avg. $431.94$279K - Mar 6, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect40 shares at avg. $425.08$17K - Mar 6, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect420 shares at avg. $426.86$179K - Mar 6, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect80 shares at avg. $427.85$34K - Mar 6, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect160 shares at avg. $429.00$69K - Mar 6, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect40 shares at avg. $429.58$17K - Mar 6, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect120 shares at avg. $430.90$52K - Mar 6, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect80 shares at avg. $435.31$35K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 6, 2026 |  MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 116 | $432.56 | $50,176 | Direct |
| Mar 6, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 160 | $434.20 | $69,472 | Direct |
| Mar 6, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 646 | $431.94 | $279,033 | Direct |
| Mar 6, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 40 | $425.08 | $17,003 | Direct |
| Mar 6, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 420 | $426.86 | $179,283 | Direct |
| Mar 6, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 80 | $427.85 | $34,228 | Direct |
| Mar 6, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 160 | $429.00 | $68,639 | Direct |
| Mar 6, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 40 | $429.58 | $17,183 | Direct |
| Mar 6, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 120 | $430.90 | $51,708 | Direct |
| Mar 6, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 80 | $435.31 | $34,825 | Direct |
1-10 of 37 transactions